ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Godden, C W
Right arrow Articles by THOMSON, A. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Godden, C W
Right arrow Articles by THOMSON, A. H
Arch Dis Child 1997;76:155-158 ( February )

Double blind placebo controlled trial of nebulised budesonide for croup

C W Godden,a M J Campbell,b M Hussey,a J J Cogswella

a Department of Paediatrics, Poole NHS Trust Hospital, Dorset, b Medical Statistics and Computing, Southampton General Hospital

Correspondence to: Dr C W Godden, Paediatric Department, Children's Unit, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey GU2 5XX.

Accepted 28 August 1996

AIMS---To determine whether nebulised budesonide improves the symptoms or shortens the duration of stay of children admitted to hospital with a clinical diagnosis of croup.
METHODS---A prospective, randomised, double blind placebo controlled trial. Patients received either nebulised budesonide or placebo every 12 hours. The main outcome measures were duration of inpatient stay and croup scores at 30 minutes, one, two, four, 12, and 24 hours.
RESULTS---87 patients (89 admissions) aged 7-116 months entered the trial. Nebulised budesonide was associated with a significant improvement in symptoms at 12 hours (95% confidence interval (CI) 1 to 3) and 24 hours (95% CI 0 to 3). Patients with an initial croup score above 3 demonstrated a significant improvement in symptoms at two hours (95% CI 1 to 3). Nebulised budesonide was also associated with a 33% reduction in the length of stay (95% CI 2% to 63%) when the confounding variables of age, initial croup score, and coryzal symptoms were taken into consideration.
CONCLUSIONS---Nebulised budesonide is an effective treatment for children admitted to hospital with a clinical diagnosis of croup.

Keywords: croup; budesonide.


© 1997 by Archives of Disease in Childhood



This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
J. W. Luria, J. A. Gonzalez-del-Rey, G. A. DiGiulio, C. M. McAneney, J. J. Olson, and R. M. Ruddy
Effectiveness of Oral or Nebulized Dexamethasone for Children With Mild Croup
Arch Pediatr Adolesc Med, December 1, 2001; 155(12): 1340 - 1345.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Corticosteroids for croup
DTB, March 1, 2000; 38(3): 22 - 24.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
T. P Klassen, A. J Tillett, J. D M Gould, C. Cates, S Jothimurugan, Z. Hassan, and M Silverman
Effectiveness of glucocorticoids in treating croup
BMJ, December 11, 1999; 319(7224): 1577a - 1577.
[Full Text]


Home page
NEJMHome page
D. W. Johnson, S. Jacobson, P. C. Edney, P. Hadfield, M. E. Mundy, and S. Schuh
A Comparison of Nebulized Budesonide, Intramuscular Dexamethasone, and Placebo for Moderately Severe Croup
N. Engl. J. Med., August 20, 1998; 339(8): 498 - 503.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. M. Jaffe
The Treatment of Croup with Glucocorticoids
N. Engl. J. Med., August 20, 1998; 339(8): 553 - 555.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1997 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health